Tranexamic Acid for Melasma

Tranexamic acid may reduce melasma pigmentation by moderating signals that stimulate pigment production. It is a medicine that can be used in selected melasma plans. It may be taken by mouth or applied to the skin, depending on clinical judgement. Its proposed skin effect is to reduce signals involved in pigment production and pigment transfer after triggers such as light or hormonal change. A dermatologist should decide whether it fits your history.

A topical product should not hurt, though mild dryness or irritation is possible. Taking the medicine by mouth does not usually cause a sensation on the skin. Tell your clinician about new discomfort, rash, swelling, chest symptoms or unusual leg pain rather than continuing without advice.

Safety depends strongly on the form used and your medical history. Before oral treatment, discuss previous blood clots, clotting disorders, stroke, kidney problems, migraine history, pregnancy, hormonal medicines and smoking. Do not start or stop oral tranexamic acid without a prescriber. Topical use still deserves review if your skin is reactive.

Melasma can return when treatment is stopped or when light and hormonal triggers continue. Results are therefore maintained through a personalised plan, daily broad-spectrum sun protection and follow-up. A clinician may change the treatment after the skin has improved.

Melasma is a long-term pigment condition, so the aim is control rather than a one-time correction. Protecting the face from daylight and visible light can support treatment. Do not judge progress from a few days of use; changes are gradual and skin tone can vary with exposure.

A dermatologist may consider tranexamic acid for people with diagnosed melasma whose pigmentation remains troublesome despite sun protection and suitable topical care. The cause and pattern should be checked first because facial darkening can have other explanations. Oral treatment is reserved for people whose history supports its use.

The provider confirms the diagnosis, reviews your medical and medication history, and chooses topical or oral treatment if appropriate. For a topical product, use the advised amount on clean, dry skin. For oral treatment, follow the exact prescription and never share tablets. Keep scheduled reviews so the plan can be adjusted.

There is no immediate recovery period for a topical routine or prescribed tablets. Pigment changes take time to become visible, and improvement can vary between areas. Continue sun protection even when the patches look lighter. A return of colour does not mean you should increase the dose yourself.

Topical use can cause redness, dryness or itching. Oral tranexamic acid has uncommon but potentially serious clot-related concerns, so urgent help is needed for sudden breathlessness, chest pain, one-sided leg swelling or sudden neurological symptoms. Your prescriber will explain personal warning signs and whether monitoring is needed.

Options may include strict light protection, topical pigment medicines, gentle skin care, chemical peels or selected device treatments. Suitability depends on skin tone, pregnancy status, trigger pattern and risk of post-inflammatory darkening. [Hydroquinone Treatment](/treatments/medical-dermatology/topical-hydroquinone-therapy/) is one topical option to discuss.

Choose a dermatologist who can distinguish melasma from other pigment conditions and assess clot risk before considering oral treatment. Bring your full medicine list and mention hormonal contraception, pregnancy plans, prior clots and kidney disease. Read more about [Melasma](/conditions/melasma/) and [Tranexamic Acid](/materials/tranexamic-acid/).